tiprankstipranks
Adverum Biotechnologies (ADVM)
NASDAQ:ADVM
US Market

Adverum Biotechnologies (ADVM) Cash flow

Compare
608 Followers

Adverum Biotechnologies Cash Flow

ADVM's free cash flow for Q3 2024 was $-21.34M. For the 2024 fiscal year, ADVM's free cash flow was decreased by $28.20M and operating cash flow was $-21.12M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -90.90M$ -108.09M$ -107.83M$ -79.29M$ -49.17M
Investing Cash Flow
$ 96.88M$ 141.72M$ 78.71M$ -280.17M$ -68.07M
Financing Cash Flow
$ 69.00K$ 607.00K$ 2.40M$ 355.99M$ 28.19M
End Cash Position
$ 76.98M$ 70.93M$ 36.70M$ 63.42M$ 66.90M
Free Cash Flow
$ -91.71M$ -119.91M$ -122.95M$ -91.14M$ -68.42M
Currency in USD

Adverum Biotechnologies Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis